Search Within

Kevin Joseph Curran

  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (54)
  2. Journal Article (36)
  3. Research Letter (2)
  4. Review (1)
Groups
  1. Center for Hematologic Malignancies (93)
  2. Pediatrics, Department of (93)
  3. Stem Cell Transplantation and Cellular Therapy Service (93)
  4. Department of Medicine (91)
  5. GSK Faculty (81)
  6. Hematologic Malignancies, Division of (78)

More Groups

People
  1. Renier Brentjens (47)
  2. Richard O'Reilly (41)
  3. Isabelle Riviere (40)
  4. Nancy Kernan (39)
  5. Jae Park (38)
  6. Michel Sadelain (36)

More People

Years
  1. 2025 (4)
  2. 2024 (7)
  3. 2023 (6)
  4. 2022 (4)
  5. 2021 (6)
  6. 2020 (8)

More Years

Publications
  1. Blood (25)
  2. Bone Marrow Transplantation (11)
  3. Biology of Blood and Marrow Transplantation (10)
  4. Cytotherapy (7)
  5. Molecular Therapy (5)
  6. Blood Advances (4)

More Publications

Publishers
  1. American Society of Hematology (30)
  2. Nature Publishing Group (21)
  3. Elsevier Inc. (11)
  4. Elsevier Science Ltd. (7)
  5. American Society of Clinical Oncology (4)
  6. Wiley Periodicals, Inc (3)

More Publishers

Results (93)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation
    Journal Article

    van Roessel, I.; Prockop, S.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; O'Reilly, R. J.; Kernan, N. A.; more...
    Cytotherapy (2020)

    Fulltext@MSK | Save
  • Early CD4+ T cell reconstruction as predictor for outcomes after allogeneic hematopoietic cell transplantation in pediatric and young adult patients: A validation cohort analyses
    Meeting Abstract

    Van Roessel, I.; Prockop, S. E.; Klein, E.; Boulad, F.; Scaradavou, A.; Spitzer, B.; Kung, A.; Curran, K.; Cancio, M.; O'Reilly, R. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Outcomes of two chemotherapy-based preparatory regimens compared to tbi-based conditioning when used with CD34(+) selected T-cell depleted alloHCT for high risk hematologic malignancies: Prospective clinical trial NCT 01119066
    Meeting Abstract

    O'Reilly, R. J.; Koehne, G.; Boulad, F.; Heller, G.; Klein, E.; Barker, J. N.; Castro-Malaspina, H.; Curran, K. J.; Hsu, K. C.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation
    Journal Article

    Prockop, S.; Doubrovina, E.; Suser, S.; Heller, G.; Barker, J.; Dahi, P.; Perales, M. A.; Papadopoulos, E.; Sauter, C.; Castro-Malaspina, H.; more...
    Journal of Clinical Investigation (2020)

    Fulltext@MSK | Save
  • Conditioning prior to CAR T cells predicts response and survival in pediatric/young adult relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K. J.; Margossian, S.; Kernan, N. A.; Boulad, F.; Cancio, M.; Prockop, S. E.; Scaradavou, A.; Spitzer, B.; Szenes, V.; Riviere, I.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL
    Meeting Abstract

    Perica, K.; Flynn, J.; Curran, K. J.; Wang, X.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; Gonen, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Conditioning prior to CD19-specific CAR (19-28Z) T cells predicts response and survival in pediatric relapse/refractory (R/R) B-ALL
    Meeting Abstract

    Curran, K.; Margossian, S.; Kernan, N.; Prockop, S.; Boulad, F.; Cancio, M.; Szenes, V.; Kung, A.; Boelens, J. J.; O'Reilly, R.; more...
    Bone Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; RivieĢ€re, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save